These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 16352590)
21. Methodological challenges in supportive and palliative care cancer research. Aktas A; Walsh D Semin Oncol; 2011 Jun; 38(3):460-6. PubMed ID: 21600378 [TBL] [Abstract][Full Text] [Related]
22. The end of biomedical journals: there is madness in their methods. Aickin M J Altern Complement Med; 2005 Oct; 11(5):755-7. PubMed ID: 16296895 [No Abstract] [Full Text] [Related]
26. Integrating integrative medicine research: what can we learn from each other? Jain S; Mills PJ J Soc Integr Oncol; 2008; 6(2):45-6. PubMed ID: 18544283 [No Abstract] [Full Text] [Related]
27. From bytes to bedside: data integration and computational biology for translational cancer research. Mathew JP; Taylor BS; Bader GD; Pyarajan S; Antoniotti M; Chinnaiyan AM; Sander C; Burakoff SJ; Mishra B PLoS Comput Biol; 2007 Feb; 3(2):e12. PubMed ID: 17319736 [No Abstract] [Full Text] [Related]
28. A new network to promote evidence-based research. Chalmers I; Nylenna M Lancet; 2014 Nov; 384(9958):1903-4. PubMed ID: 25435440 [No Abstract] [Full Text] [Related]
29. Linked in: ASCO, NCI tap health information technology to improve cancer prevention, care, and research. Printz C Cancer; 2012 Dec; 118(23):5721-2. PubMed ID: 23165698 [No Abstract] [Full Text] [Related]
31. The changing landscape of urologic oncology: initiating systemic therapies, interventional skills, and clinical trials. Introduction. Lin DW; Shore ND Urol Oncol; 2012; 30(4 Suppl):S1. PubMed ID: 22795074 [No Abstract] [Full Text] [Related]
32. Issues of sample size in sensitivity and specificity analysis with special reference to oncology. Juneja A; Sharma S J Cancer Res Ther; 2015; 11(2):482-4. PubMed ID: 26148624 [TBL] [Abstract][Full Text] [Related]
33. Colorectal carcinoma: overview of clinical research and management 2011. Krishnamurthi SS; Meropol NJ Semin Oncol; 2011 Aug; 38(4):481-2. PubMed ID: 21810506 [No Abstract] [Full Text] [Related]
34. Preclinical rare cancer research to inform clinical trial design. Barker HE; Scott CL Nat Rev Cancer; 2019 Sep; 19(9):481-482. PubMed ID: 31263218 [No Abstract] [Full Text] [Related]
35. Evidence-based alternative medicine? Borgerson K Perspect Biol Med; 2005; 48(4):502-15. PubMed ID: 16227663 [TBL] [Abstract][Full Text] [Related]
36. Academic versus industry-driven research in upper gastrointestinal cancer: sinners and saints. Hendlisz A; Charette N; Awada A; Deleporte A Curr Opin Oncol; 2013 Jul; 25(4):407-8. PubMed ID: 23673411 [No Abstract] [Full Text] [Related]
37. Education section - Studies Within A Trial (SWAT). J Evid Based Med; 2012 Feb; 5(1):44-5. PubMed ID: 23528122 [No Abstract] [Full Text] [Related]
38. Evidence-based oncology. Kagan AR Cancer Invest; 2004; 22(2):321-3. PubMed ID: 15199614 [No Abstract] [Full Text] [Related]
39. Reflections on ethical concerns arising from the incorporation of results of randomized trials of antineoplastic therapy into routine clinical practice. Markman M Cancer Invest; 2005; 23(8):735-40. PubMed ID: 16377592 [TBL] [Abstract][Full Text] [Related]
40. From studying patient treatment to studying patient care: arriving at methodologic crossroads. Verhoef MJ; Leis A Hematol Oncol Clin North Am; 2008 Aug; 22(4):671-82, viii-ix. PubMed ID: 18638695 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]